OTTAWA, Ontario, Jan. 25, 2018 /Weed Wire/ – Health Canada is introducing two targeted changes to the physical security requirements under the Access to Cannabis for Medical Purposes Regulations (ACMPR) that must be respected by licensed producers (LP) of cannabis for medical purposes.
Tag Archives: Access to Cannabis for Medical Purposes Regulations
VICTORIA, British Columbia, Oct. 19, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“EHT”) (TSXV: EMH; OTCQX: EMHTF), through Emerald Health Botanicals Inc. (“Emerald”), its wholly owned subsidiary and a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), has submitted license applications to Health Canada for approval of two new growing sites.
OTTAWA, Ontario, May 26, 2017 /Weed Wire/ — Health Canada is introducing several improvements to its medical cannabis program that aim to streamline the application process for issuing production licenses and enable increased production under the Access to Cannabis for Medical Purposes Regulations (ACMPR).
In a Connecticut budget bill introduced on May 16, 2017, Democrats included legalizing, regulating and taxing recreational marijuana. According to the Marijuana Policy Project, the proposal would allow adults 21 and older to buy marijuana from dispensaries.
Investors are becoming more and more impressed with the job CEO Terry Booth and his team are doing at Aurora Cannabis Inc. After posting strong Q2 results and closing a C$75 million financing, there’s a lot to like with company.
On Jan. 10, 2017, Health Canada authorized James E. Wagner Cultivation in Ontario to start cultivating medical cannabis, making it the 38th licensed producer in Canada and the first producer of 2017 licensed under the Access to Cannabis for Medical Purposes Regulations.
“Obtaining our license to sell cannabis oils is another major milestone for Aurora, said Terry Booth, chief executive.
In the last few months, the medical marijuana growers have dominated the trading activity on the TSX Venture in terms of dollar volume almost exclusively, belying a persistent interest from investors in Canada and the United States.